Non-vitamin K oral anticoagulants in hypertrophic cardiomyopathy patients undergoing catheter ablation of atrial fibrillation.
Antonio CretaRoss J HunterMark J EarleyMalcolm FinlayMehul DhinojaSimon SportonAnthony ChowSaidi A MohiddinSerge BovedaPedro AdragaoZeynab JebberiDaniel MatosRichard J SchillingPier D LambiaseRui Andre ProvidenciaPublished in: Journal of cardiovascular electrophysiology (2020)
These preliminary data suggest that NOACs are at least as safe and effective as VKAs in patients with HCM undergoing catheter ablation for AF.
Keyphrases
- atrial fibrillation
- catheter ablation
- oral anticoagulants
- hypertrophic cardiomyopathy
- patients undergoing
- left atrial
- left ventricular
- left atrial appendage
- direct oral anticoagulants
- heart failure
- electronic health record
- percutaneous coronary intervention
- big data
- machine learning
- coronary artery disease
- mitral valve
- data analysis
- acute coronary syndrome